ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹7,709 Cr | ₹6,341 Cr | ₹6,064 Cr | ₹7,230 Cr | ₹6,961 Cr |
What is the latest Total Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹7,709 Cr |
| Mar2024 | ₹6,341 Cr |
| Mar2023 | ₹6,064 Cr |
| Mar2022 | ₹7,230 Cr |
| Mar2021 | ₹6,961 Cr |
How is Total Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,709 Cr | 21.57 | |
| Mar2024 | ₹6,341 Cr | 4.58 | |
| Mar2023 | ₹6,064 Cr | -16.13 | |
| Mar2022 | ₹7,230 Cr | 3.86 | |
| Mar2021 | ₹6,961 Cr | - | |
Compare Total Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹15,242.4 Cr | -3.1% | -8.4% | -21.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -3.1% |
-8.4% |
-21.3% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses